APA (7th ed.) Citation

Chris Wynne, Christian Schwabe, Emmanuelle Vincent, Armin Schueler, Janka Ryding, Martin Ullmann, . . . Michael Stahl. (2020). Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial. Wiley.

Chicago Style (17th ed.) Citation

Chris Wynne, Christian Schwabe, Emmanuelle Vincent, Armin Schueler, Janka Ryding, Martin Ullmann, Vishal Ghori, Radmila Kanceva, and Michael Stahl. Immunogenicity and Safety of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta® in Healthy Subjects: A Randomized, Double‐blind Trial. Wiley, 2020.

MLA (9th ed.) Citation

Chris Wynne, et al. Immunogenicity and Safety of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta® in Healthy Subjects: A Randomized, Double‐blind Trial. Wiley, 2020.